Investigators compared the efficacy and safety of suvemcitug plus chemotherapy vs chemotherapy plus placebo for patients with platinum-refractory or resistant ovarian cancer.

Socioeconomic status of cancer survivors or the neighborhood in which they live has a significant effect on their perceived work ability and functional outcomes.

In this global network study, researchers examined vitamin B12 levels as a possible biomarker for outcomes in colon cancer.

The investigational cortisol modulator relacorilant plus nab-paclitaxel improved survival in platinum-resistant ovarian cancer in a phase 3 study.

Investigators compared clinical outcomes with docetaxel rechallenge vs cabazitaxel in patients with mCRPC who did not experience disease progression during prior administration of docetaxel for mCRPC.

The FDA's Fast Track designation helps to accelerate the development and review of products for serious and life-threatening conditions.

In this retrospective study, researchers explored whether reducing osimertinib dose in EGFR-mutated metastatic NSCLC patients who experienced adverse events would worsen survival.

BTK inhibitors (BTKi) in mantle cell lymphoma (MCL) are examined by Tycel J. Phillips, MD, particularly as potential first-line therapy.

Experts are researching and exploring ways to standardize death and dying education across US medical schools. (HealthDay News) — There is considerable variation in how death and dying are taught in ...

In this study, researchers evaluated patients who had incomplete cCRT or experienced progression during or within 42 days of receiving cCRT, with an aim of identifying risk factors for these outcomes.

Investigators sought to determine the cost-effectiveness of home- versus clinic-based anal cancer screening for increasing uptake among sexual and gender minorities.

Dr Andrew Howard, chairman and president of the Kidney Transplant Collaborative, told the Associated Press that the drop off in kidney transplants would have been larger if not for a small increase of ...